Convenient formulation with twice-daily dosing1,2
Your patients living with amyotrophic lateral sclerosis (ALS) and their caregivers can easily learn how to take or administer TIGLUTIK, the first and only oral suspension form of riluzole.1
Patients take 10 mL of oral suspension TIGLUTIK twice a day. This dose includes the same 50 mg found in a riluzole tablet.1,2
How TIGLUTIK is prepared and administered1
STEP 1: Gently shake the TIGLUTIK bottle for at least 30 seconds, continually rotating it 180°, so that the contents appear uniform, before use.
STEP 2: Remove the tip of the syringe and insert the syringe into the opening of the TIGLUTIK bottle.
STEP 3: Turn the bottle upside down and slowly pull the plunger on the syringe to withdraw 10 mL of TIGLUTIK.
STEP 4: Check to ensure the dose is correct and place the tip of the syringe in the center of the mouth, while completely pressing down on the plunger. Swallow all of the contents in the syringe.
STEP 5: Rotate the bottle right-side up and remove the syringe. Wash the syringe with water only and safely store TIGLUTIK.
Refer to the TIGLUTIK Instructions for Use for complete instructions.
- TIGLUTIK (riluzole) [package insert]. Berwyn, PA: ITF Pharma; September 2018.
- Rilutek (riluzole) [package insert]. Cary, NC: Covis Pharmaceuticals, Inc.; April 2016.